Plain-English translation of NCT05783271 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Bladder Cancer research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Bladder cancer is the second most common cancer of the urinary system, and doctors need reliable ways to tell whether it has spread into the muscle layer of the bladder. This study evaluates whether a special type of MRI scan—using different imaging techniques together—can accurately diagnose bladder cancer and determine how advanced it is. The researchers will compare two MRI methods to see which one works better.
Currently, doctors use MRI to stage bladder cancer, but the accuracy isn't perfect. This trial exists to see if adding a contrast dye injection to the standard MRI scan (called multi-parametric MRI) helps doctors more accurately tell the difference between cancers that are contained in the bladder lining versus those that have invaded the muscle layer—a distinction that completely changes how the cancer is treated.
You likely qualify if…
You likely don't qualify if…
You will undergo MRI scans of your bladder—the same type of imaging your doctor may have already ordered. The study compares two slightly different scanning approaches: one without contrast dye and one with contrast dye injected into your vein. Expert radiologists will review your scans and score them using a standardized system to help determine whether your cancer has invaded the muscle layer. Your existing scans and results will be evaluated; no additional biopsies or procedures are required for this diagnostic study.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
Egypt
Sponsor
Assiut University
Enrollment target
~58 participants
Started
December 2025
Primary completion
July 2026
Last updated on clinicaltrials.gov in October 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Hassan Megally, proff
Newvalley University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.